Latest News & Features
Regulation & Industry
While promising science draws in buyers, intellectual property determines the price, terms, and viability of an agreement. LSIPR digs into what buyers are looking for—and the biggest turn-offs that destroy a deal. 25 August 2026
Regulation & Industry
Labour MP for Stockton North takes up a new role as Minister for Science, Innovation and Investment within Andy Burnham’s government. 24 August 2026
Careers
The four-person team adds significant life sciences experience to the litigation boutique, drawn to move firms by Stris’ “outstanding trial lawyers” and “sophisticated appellate capabilities”. 24 August 2026
Pharma
Under the terms of the agreement, which resolves all patent litigation between the biopharma rivals, Teva now has a launch date for its own version of Aurinia's Lupkynis. 21 August 2026
Biotech
Three disputed sequencing patents took the spotlight as the Federal Circuit weighed challenges to a trio of PTAB rulings. 20 August 2026
Pharma
A reported deal with an Indian manufacturer could clear a path for a future generic launch as the Korean drugmaker leverages one of its biggest US products. 20 August 2026
Pharma
Questions over braille on a generic sleep disorder drug label will face fresh scrutiny after an appeals court found fault with the FDA’s approach. 19 August 2026
MedTech
The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue. 18 August 2026
Careers
The new partner counts pharmaceuticals and life sciences among his specialisms and previously worked in-house at Sandoz. 18 August 2026
Careers
The IP advocacy group has turned to former USPTO acting director Coke Morgan Stewart as it enters what it calls a “new chapter”. 17 August 2026